To improve the delivery and efficacy of siRNA to NB xenografts, a bispecific antibody for recognition of EGFR and methoxy polyethylene glycol (PEG) is combined with a PEGylated siRNA lipid nanoparticle, which leads to increased cell targeting against EGFR+ high-risk NB cells [134]. Here, EGFR is linked to neuroblastoma.